Ambrocio-Ortiz, E.; Pérez-Rubio, G.; Del Ángel-Pablo, A.D.; Buendía-Roldán, I.; Chávez-Galán, L.; Hernández-Zenteno, R.d.J.; Ramírez-Venegas, A.; Rojas-Serrano, J.; Mejía, M.; Pérez-Padilla, R.;
et al. Angiotensin-Converting Enzyme 2 (ACE2) in the Context of Respiratory Diseases and Its Importance in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection. Pharmaceuticals 2021, 14, 805.
https://doi.org/10.3390/ph14080805
AMA Style
Ambrocio-Ortiz E, Pérez-Rubio G, Del Ángel-Pablo AD, Buendía-Roldán I, Chávez-Galán L, Hernández-Zenteno RdJ, Ramírez-Venegas A, Rojas-Serrano J, Mejía M, Pérez-Padilla R,
et al. Angiotensin-Converting Enzyme 2 (ACE2) in the Context of Respiratory Diseases and Its Importance in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection. Pharmaceuticals. 2021; 14(8):805.
https://doi.org/10.3390/ph14080805
Chicago/Turabian Style
Ambrocio-Ortiz, Enrique, Gloria Pérez-Rubio, Alma D. Del Ángel-Pablo, Ivette Buendía-Roldán, Leslie Chávez-Galán, Rafael de Jesús Hernández-Zenteno, Alejandra Ramírez-Venegas, Jorge Rojas-Serrano, Mayra Mejía, Rogelio Pérez-Padilla,
and et al. 2021. "Angiotensin-Converting Enzyme 2 (ACE2) in the Context of Respiratory Diseases and Its Importance in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection" Pharmaceuticals 14, no. 8: 805.
https://doi.org/10.3390/ph14080805
APA Style
Ambrocio-Ortiz, E., Pérez-Rubio, G., Del Ángel-Pablo, A. D., Buendía-Roldán, I., Chávez-Galán, L., Hernández-Zenteno, R. d. J., Ramírez-Venegas, A., Rojas-Serrano, J., Mejía, M., Pérez-Padilla, R., Guadarrama-Pérez, C., & Falfán-Valencia, R.
(2021). Angiotensin-Converting Enzyme 2 (ACE2) in the Context of Respiratory Diseases and Its Importance in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection. Pharmaceuticals, 14(8), 805.
https://doi.org/10.3390/ph14080805
